Why AstraZeneca Pausing Its COVID-19 Vaccine Trial May Be Good News

September 10, 2020

(ABC News) – The promising vaccine candidate created by researchers at Oxford had been marching through rounds of clinical trials before word of the voluntary pause came down Tuesday night. Trial participants in the U.S had started injections just last week. Specialists ABC News spoke with said they welcomed the pause.